AKT1 and breast carcinoma: Furthermore, the restoration of AKT or constitutively active AKT expression could rescue the inhibition of cell proliferation by ANP32B deficiency, suggesting the inhibition of cell proliferation by ANP32B deficiency is primarily mediated through AKT activation in breast cancer cells.